Taysha Gene Therapies, Inc. TSHA Finance Lease Liability, Current
Finance Lease Liability, Current at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityCurrent.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s finance lease liability, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s finance lease liability, current?
- Taysha Gene Therapies, Inc. (TSHA) reported finance lease liability, current of $275K in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s finance lease liability, current changed year-over-year?
- Taysha Gene Therapies, Inc.'s finance lease liability, current decreased by 31.6% year-over-year, from $402K to $275K.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s finance lease liability, current?
- Over 3 years (2022 to 2025), Taysha Gene Therapies, Inc.'s finance lease liability, current has grown at a 5.8% compound annual growth rate (CAGR), from $320K to $379K.
- What does finance lease liability, current mean?
- Finance lease liabilities (current) represent the portion of lease obligations that are due to be paid within the next twelve months. These obligations arise from long-term contracts where the company effectively controls the leased asset. This metric is critical for assessing near-term liquidity and cash flow requirements.